Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full ...

Larimar Therapeutics, Inc. ('Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an ...

Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...

As the global population climbs toward 10 billion and climate change strains farmland, scientists are searching for new ways to feed the world. A group of Cornell food science researchers say one ...

Drugmakers thought they had the FDA's buy-in to approve a therapy to treat a type of cancer that can quickly turn deadly. The agency, however, rejected it.

Consistently featured on the Forbes’ list of The World’s Most Powerful Women since 2011, Mazumdar-Shaw will also serve as the keynote speaker at the May 16 commencement ceremony.

ABU DHABI, 25th February, 2026 (WAM) -- NYU Abu Dhabi and RTW Investments, LP (“RTW”) Wednesday announced a strategic collaboration to advance executive education, thought leadership, and cross-sector ...

New AI-Driven Planning Platform Designed to Unlock a New Class of Disease-Modifying Therapies for CNS Disorders MUNICH & REDWOOD CITY, Calif.--(BUSIN ...

Tether stablecoin payments get a boost as Tether invests in Whop, enhancing user transactions and expanding to new markets.

For 4Q2025, Nomura Small Cap Core Institutional Class shares gained although the Fund underperformed its Russell 2000 Index ...

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) are surging Wednesday following a robust earnings report released before the bell.